BioCentury | May 5, 2014
Clinical News

Zolpidem-containing medicines regulatory update

...March 17). The drugs include generics, as well as Ambien and Ambien CR from Sanofi; Edluar...
BioCentury | Apr 14, 2014
Company News

Meda, Valeant Pharmaceuticals sales and marketing update

...buccal soluble film; and insomnia drug Sublinox zolpidem. Meda will grant Valeant a license for Sublinox...
...once the JV in Canada is terminated. Onsolis is an adhesive disc formulation of fentanyl. Sublinox...
BioCentury | Mar 17, 2014
Clinical News

Zolpidem-containing medicines regulatory update

...mental function. The drugs include generics, as well as Ambien and Ambien CR from Sanofi; Edluar...
BioCentury | Jul 22, 2013
Clinical News

Zolpidem-containing medicines regulatory update

...the review. The drugs include generics, as well as Ambien and Ambien CR from Sanofi; Edluar...
BioCentury | Jan 14, 2013
Clinical News

Zolpidem-containing medicines regulatory update

...require alertness. The drugs include generics and well as Ambien and Ambien CR from Sanofi; Edluar...
...women will be lowered to 5 mg from 10 mg for the immediate-release products Ambien, Edluar...
BioCentury | Jun 25, 2012
Clinical News

Edluar regulatory update

...sublingual, mucoadhesive zolpidem tablet is marketed in the U.S. as Edluar and in Canada as Sublinox...
...and in Canada as Sublinox to treat short-term insomnia. Meda acquired exclusive, worldwide rights to Edluar...
...21, 2008). Orexo AB (SSE:ORX), Uppsala, Sweden Meda AB (SSE:MEDAA), Solna, Sweden Product: Edluar ( Sublinox...
BioCentury | Aug 1, 2011
Clinical News

Sublinox edluar regulatory update

...Health Canada approved an NDS for Sublinox zolpidem for short-term treatment and symptomatic relief of insomnia...
...in the U.S. as Edluar to treat short-term insomnia. Meda acquired exclusive, worldwide rights to Sublinox...
...April 21, 2008). Orexo AB (SSE:ORX), Uppsala, Sweden Meda AB (SSE:MEDAA), Solna, Sweden Product: Sublinox edluar...
BioCentury | Aug 24, 2009
Company News

Meda sales and marketing update

...Meda launched 5 and 10 mg sublingual Edluar zolpidem (formerly Sublinox ) in the U.S. for...
BioCentury | Mar 23, 2009
Clinical News

Edluar regulatory update

...FDA approved an NDA from Orexo for sublingual Edluar zolpidem (formerly Sublinox) to treat insomnia. The...
...U.S. next half. Orexo AB (SSE:ORX), Uppsala, Sweden Product: Edluar ( OX 22 ; formerly Sublinox...
BioCentury | Aug 11, 2008
Company News

Meda, Valeant Pharmaceuticals International deal

...the partners will form JVs in Australia, Canada and Mexico to develop and commercialize Meda’s Sublinox...
...profit sharing. Meda has exclusive, worldwide rights from Orexo AB (SSE:ORX, Uppsala, Sweden) to market Sublinox...
Items per page:
1 - 10 of 28